Trulicity
Payments companies reported to CMS as associated with Trulicity. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Trulicity, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Trulicity
These are the largest totals companies reported as associated with Trulicity. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ralph Duda | Springfield, MO | Endocrinology, Diabetes & Metabolism | $3,485.70 |
| Michael Bush | Beverly Hills, CA | $3,200.00 | |
| Paul Thompson | Hartford, CT | Cardiovascular Disease | $3,000.00 |
| Brian Deyarmin | Bethel Park, PA | Family Medicine | $2,750.00 |
| David Robertson | Atlanta, GA | Endocrinology, Diabetes & Metabolism | $2,499.37 |
| Swarna Varma | Pittsburgh, PA | Endocrinology, Diabetes & Metabolism | $2,275.17 |
| Michael Favorito | Wilmington, NC | Endocrinology, Diabetes & Metabolism | $1,317.78 |
| Robert Ennis | Meridian, ID | Endocrinology, Diabetes & Metabolism | $1,300.00 |
| Jeannie Baquero | San Antonio, TX | Endocrinology, Diabetes & Metabolism | $1,300.00 |
| Philip Levin | Baltimore, MD | Endocrinology, Diabetes & Metabolism | $1,050.00 |
Prescribed Trulicity?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.